Alprazolam

GPTKB entity

Statements (55)
Predicate Object
gptkbp:instanceOf benzodiazepine
recreational drug
gptkbp:approvalYear 1981
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode N05BA12
gptkbp:brand gptkb:Alprax
gptkb:Niravam
gptkb:Xanax
gptkbp:CASNumber 28981-97-7
gptkbp:category benzodiazepine
sedative
anticonvulsant
muscle relaxant
gptkbp:chemicalClass triazolobenzodiazepine
gptkbp:contraindication acute narrow-angle glaucoma
itraconazole use
ketoconazole use
gptkbp:controlledSubstanceSchedule Schedule IV (US)
gptkbp:developedBy gptkb:Upjohn
gptkbp:discoveredBy gptkb:Upjohn
gptkbp:eliminationHalfLife 11 hours
gptkbp:excretion urine
gptkbp:firstSynthesized 1971
gptkbp:hasMolecularFormula C17H13ClN4
https://www.w3.org/2000/01/rdf-schema#label Alprazolam
gptkbp:interactsWith gptkb:beer
opioids
other CNS depressants
gptkbp:legalStatus prescription only
gptkbp:marketedAs gptkb:Pfizer
gptkbp:mechanismOfAction GABA-A receptor positive allosteric modulator
gptkbp:meltingPoint 228°C
gptkbp:metabolism liver
gptkbp:pregnancyCategory D (US)
gptkbp:PubChem_CID 2033
2118
gptkbp:riskFactor abuse
overdose
dependence
gptkbp:routeOfAdministration oral
gptkbp:sideEffect addiction
fatigue
drowsiness
impaired coordination
memory impairment
withdrawal symptoms
gptkbp:solubility slightly soluble in water
gptkbp:UNII YW7N9M0A4I
gptkbp:usedFor gptkb:generalized_anxiety_disorder
gptkb:panic_disorder
anxiety disorders
gptkbp:bfsParent gptkb:Schedule_IV
gptkb:Trika
gptkb:Benzodiazepines
gptkbp:bfsLayer 6